South San Francisco, CA · Founded 2010 · Privately Held (backing)
Operator of a biotechnology firm intended to develop therapies that improve the body's healing response and repair damaged tissue. Silver Creek Pharmaceuticals is based in South San Francisco, CA and was founded in 2010. Its last reported valuation was $60 million in Feb 2018. It has raised $57.1 million across 2 recorded rounds; the latest was a $9.2 million early-stage round in Jan 2022.
Last reported valuation
$60.0M
Oct 2026
Priced at
—
Total raised
$57.1M
Last round
Early Stage VC
Jan 2022
No prints on record
No secondary trades in Silver Creek Pharmaceuticals shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Silver Creek Pharmaceuticals with a free account
·Watch Silver Creek Pharmaceuticals: the Monday email on marks, rounds and moves
Where Silver Creek Pharmaceuticals prices come from
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Silver Creek Pharmaceuticals stock.
